Home

Who We Are

We research, innovate and manufacture orodispersible dosage forms that are unique, patented and enhance patient compliance and accessibility

What We Do

Create innovative process technology platforms to enhance the effectiveness and utility of existing molecules
We improve absorption and release of medications by avoiding first pass metabolism, providing convenience, ease of use and typically, reduced amounts of drug actives for improved safety profiles

About us

OUR CAPABILITIES

Pairing known molecules with a proven CURE drug delivery system, to improve absorption and eliminate the discomfort experienced from taking painful injections or inefficient oral solids

Research &
Development

Relentless focus on science, innovation, and collaboration

Product & Process
Development

Leveraging Advanced Technologies & Practices

cGMP Manufacturing
Facility

FDA Registered and cGMP Certified Facility.
Our 25,000 sqft facility, state of the art cGMP Manufacturing / Pursuing Steps For Commercial Pharmaceutical Manufacturing Commercial Use

Intellectual
Property

43 Issued & Pending US Patents
A vast IP portfolio

CUREFilm®

The CURE Solution:
A Unique Dosage Form

Unique Attributes

  • Sublingual and buccal delivery options absorb rapidly and directly into the bloodstream, avoiding first-pass metabolism
  • Eliminates the need for painful injections improving patient compliance
  • No need for tablets, swallowing or chewing
  • Uniform drug distribution allows for precision dosing

Dose Loading

  • CUREfilm® can accommodate most actives up to 200mg
  • Stable at room temperature; no refrigeration required

Convenience

  • Easy to carry
  • Very light weight
  • Extremely efficient to ship

Applications

  • Designed for pharmaceuticals, vaccines and nutraceuticals
  • Ideal for rural, underserved markets

INITIAL COMPANY

Growth Pillars

THE PROBLEM

Traditional Oral Delivery Is Flawed

Almost 70% of Americans are on prescription medication. Oral drug delivery is the most preferred route of drug administration.

POOR BIOAVAILABILITY

For many molecules given orally, only a fraction of the administered dose will make it to the bloodstream due to poor solubility or degradation in the GI tract and liver, as a result of 1st pass metabolism

SIDE
EFFECTS

When only a fraction of the administered dose reaches the blood, more drug needs to be given which can cause GI upset & irritation and (in some cases), liver toxicities

NON-ADHERENCE

According to the NIH, Seventy-five percent of Americans have trouble taking their medicine as directed. This lack of adherence is costing many people their good health and the health-care system billions of dollars
© 2024 Cure Pharmaceutical. All rights reserved.